Aqueous humor and serum penetration of tacrolimus after topical and oral administration in rats: an absorption study
- PMID: 19668467
- PMCID: PMC2699987
Aqueous humor and serum penetration of tacrolimus after topical and oral administration in rats: an absorption study
Abstract
Purpose: To investigate the penetration of tacrolimus to the aqueous and serum after topical and oral administration.
Methods: Thirty Wistar rats were divided into three groups. In the first group (n = 12), a single dose of 0.3 % isotonic tacrolimus solution was applied topically to the rat eyes. The second group (n = 12), received 0.1 mg/kg/day tacrolimus for three days. In control group (n = 6), the rats were administered a single drop of 0.3% salin solution topically. Following collection of samples, the amounts of tacrolimus in aqueous and serum samples were compared with each other.
Results: In group I, the mean concentration of tacrolimus was 35.16 ng/ml in aqueous and 2.22 ng/ml in serum. In group II, the mean concentration of tacrolimus was 13.08 ng/ml in aqueous and 13.45 ng/ml in serum. There was no significant difference in the serum concentration levels of tacrolimus between group I and control group. However there was a significant difference of the drug concentrations in aqueous between the groups (p < 0.001). The mean aqueous and serum concentrations of tacrolimus in group II, differed significantly from the mean concentrations in group I (p < 0.001) and the control group (p < 0.001).
Conclusion: Tacrolimus may be a promising treatment modality in intraocular inflammation by topical application besides systemic administration.
Keywords: FK506; humor aqueous; penetration into the eye; systemic application; tacrolimus; topical application.
References
-
- Fitzgerald P, Hadgraft J, Wilson CG. A gamma-scintigraphic evaluation of microparticulate ophthalmic delivery systems: liposomes and nanoparticles. Int J Pharm. 1987;40:81–8.
-
- Hikita N, Chan CC, Whitcup SM, et al. Effects of topical FK506 on endotoxin-induced uveitis (EIU) in the Lewis rat. Curr Eye Res. 1995;14:209–14. - PubMed
-
- Hikita N, Lopez JS, Chan CC, et al. Use of topical FK506 in a corneal graft rejection model in Lewis rats. Invest Ophthalmol Vis Sci. 1997;38:901–9. - PubMed
-
- Honbo T, Koyabashi M, Hane K, et al. The oral dosage form of FK-506. Transplant Proc. 1987;19(Suppl. 6):17–22. - PubMed
LinkOut - more resources
Full Text Sources
